antisense oligonucleotides (NCI)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameantisense oligonucleotides (NCI)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionFibroblast growth factors modulators
TargetsFibroblast growth factors
Therapy Area/IndicationsSarcoma, Kaposi
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsSarcoma, Kaposi

Other Information

ATC CodeN/A
Related LinksN/A